Lydon Nicholas 4
4 · Blueprint Medicines Corp · Filed Jun 23, 2023
Insider Transaction Report
Form 4
Lydon Nicholas
Director
Transactions
- Award
Common Stock
2023-06-21+2,600→ 55,784 total - Award
Stock Option (Right to Buy)
2023-06-21+5,300→ 5,300 totalExercise: $63.66Exp: 2033-06-21→ Common Stock (5,300 underlying)
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of a grant of restricted stock units. The restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) June 21, 2024 and (ii) the next annual meeting of the Issuer's stockholders. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This option vests with respect to 100% of the shares underlying the option on the earlier of (i) June 21, 2024 and (ii) the next annual meeting of the Issuer's stockholders.